Recruitment Data Policies Global Alzheimer Disease Marketing Lead

UCB•Raleigh, NC

6d•Hybrid

About The Position

We are looking for a strategic, collaborative, and insights-driven Global Alzheimer’s Disease Marketing Lead (Director-level) to join our Stakeholder Integration team. This role involves shaping the commercialization of a post-proof-of-concept asset in Alzheimer's disease. The successful candidate will leverage their direct disease-area experience to build UCB's understanding of the market, patients, caregivers, diagnosis, biomarkers, and the healthcare system, translating this knowledge into development and commercial choices. This role works closely with the Global Stakeholder Integrator, who leads overall commercial strategy and cross-functional integration, and collaborates with cross-functional colleagues responsible for commercial strategy, asset development, evidence generation, patient access, and investment decisions. The position requires leading collaboration and commercial decision-making across functions and geographies while incorporating external stakeholder perspectives into asset strategy.

Requirements

Bachelor’s degree.
10+ years of pharmaceutical strategy, marketing, or commercialization experience.
2+ years direct Alzheimer’s disease or dementia experience.
2+ years experience supporting a development-stage, post-proof-of-concept, or pre-launch asset.

Nice To Haves

Experience developing market assessments, forecasts, scenarios, or business cases
Strong understanding of Alzheimer’s diagnosis, biomarkers, stakeholders, and treatment pathways.
U.S. pharmaceutical commercialization experience.
Global pharmaceutical strategy or commercialization experience.
Experience supporting partnered or co-development assets.
Strong business judgment and ability to synthesize incomplete information.
Demonstrated success leading through influence across functions and geographies.

Responsibilities

Build UCB's Alzheimer's disease knowledge and translate patient, caregiver, stakeholder, diagnostic, access, and competitive insights into asset choices.
Lead the global cross-functional forum for learning, collaboration and commercial decision making.
Develop the patient population and indication vision, value proposition, positioning, and commercialization strategy.
Define the market-development priorities required to support future adoption, including diagnosis, biomarkers, referral and treatment pathways, healthcare infrastructure, and care delivery.
Develop market assessments, forecasts, business cases, and commercialization scenarios, including key assumptions, uncertainties, and capability needs.
Support evaluation of development and partnering scenarios through commercial assessment of strategic options, assumptions, opportunities, and risks.
Bring external stakeholder perspectives into asset decisions and translate the work into clear recommendations for the Asset team.